Condition: Fatigue · Attention Deficit Hyperactivity Disorder · Attention Deficit Disorder · Sponsor: Rochester Center for Behavioral Medicine
The goal of this clinical trial is to study the impact of Dyanavel on co-occuring fatigue in adults with Attention Deficit/Hyperactivity Disorder. The main question it aims to answer is whether Dyanavel XR leads to a statistically significant reduction in fatigue compared to placebo, as measured by the Fatigue Symptom Inventory.
This description comes directly from the study's public registry record.
Jaime Saal, MA · 2486088800 · jsaal@rcbm.net
Always discuss trial participation with your own doctor first.
| Rochester Center for Behavioral Medicine | Rochester Hills, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06248229